Mustang Bio, Inc. (MBIO) Earnings History
Net Loss11 years of earnings data (2015–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Mustang Bio, Inc. (MBIO) Earnings Overview
As of June 29, 2026, Mustang Bio, Inc. (MBIO) reported trailing twelve-month net income of -$3M, reflecting +84.8% year-over-year growth. The company earned $-0.40 per diluted share over the past four quarters.
Looking at the long-term picture, MBIO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2025, representing a new all-time high.
Mustang Bio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FATE (-$130M net income, -2051.1% margin), ALLO (-$174M net income), CRSP (-$569M net income, -16569.8% margin), MBIO has comparable earnings metrics. Compare MBIO vs FATE →
MBIO Earnings vs Peers
Earnings metrics vs comparable public companies
MBIO Historical Earnings Data (2015–2025)
11 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$2M | +87.8% | -$2M | $-0.39 | - | - |
| 2024 | -$16M | +69.5% | -$16M | $-2.57 | - | - |
| 2023 | -$52M | +33.4% | -$51M | $-6.00 | - | - |
| 2022 | -$78M | -16.8% | -$76M | $-11.25 | - | - |
| 2021 | -$66M | -10.6% | -$67M | $-11.40 | - | - |
| 2020 | -$60M | -24.6% | -$57M | $-17.10 | - | - |
| 2019 | -$48M | -57.1% | -$46M | $-20.03 | - | - |
| 2018 | -$31M | +2.0% | -$31M | $-17.07 | - | - |
| 2017 | -$31M | -147.3% | -$32M | $-18.58 | - | - |
| 2016 | -$13M | -183.3% | $11M | $-7.24 | - | - |
| 2015 | -$4M | - | -$4M | $-6.70 | - | - |
Download Data
Export MBIO earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
11+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MBIO — Frequently Asked Questions
Quick answers to the most common questions about buying MBIO stock.
What is MBIO earnings per share (EPS)?
MBIO trailing twelve-month (TTM) diluted EPS is $-0.40, reflecting +84.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2015 to 2025 is available in the table on this page.
What is Mustang Bio, Inc.'s net income?
Mustang Bio, Inc. (MBIO) trailing twelve-month net income is $-3M as of 2025. Earnings grew +84.8% year-over-year.
Is MBIO profitable?
MBIO is not currently profitable on a TTM basis, reporting a net loss of $-3M. Net margin is N/A. Investors should monitor for a return to profitability.
What is MBIO's earnings growth rate?
MBIO compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2015 to 2025.
What are MBIO's profit margins?
Mustang Bio, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -67.9%.
Is MBIO growing earnings?
Yes, MBIO earnings are accelerating — EPS growth of +84.8% exceeds the 5-year CAGR of N/A. TTM net income reached $-3M. Earnings momentum is strengthening.
What was MBIO's best earnings year?
Mustang Bio, Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 2025. Earnings history on this page spans 2015 to 2025 and includes all annual and quarterly figures.
What were MBIO's earnings last quarter?
MBIO's most recent reported quarter was Q1 2026. Net income was $-955000.00 with diluted EPS of $-0.14. For a full breakdown of all quarters, see the quarterly earnings table on this page.